Companies including Daewon and Ahngook challeges to ezetimibe complex market
Korean companies are developing fierce competition in the market of complexes having the more powerful function to inhibit cholesterol than the combination of statin and ezetimibe.
They all are planning to launch their own generics in different times, but have the same goal to localize the mark...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
